Literature DB >> 11470036

Panic disorder.

M H Rapaport1, C Barrett.   

Abstract

In this article, the authors review the most recent advances in the pharmacotherapy, psychotherapy, and combined therapy for panic disorder. The authors focus on peer-reviewed data and on pragmatic clinical approaches that may help patients suffering from panic disorder.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11470036     DOI： 10.1007/s11920-001-0022-1

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


  59 in total

Review 1.  Flawed meta-analyses comparing psychotherapy with pharmacotherapy.

Authors:  D F Klein
Journal:  Am J Psychiatry       Date:  2000-08       Impact factor: 18.112

2.  Brief cognitive therapy for panic disorder: a randomized controlled trial.

Authors:  D M Clark; P M Salkovskis; A Hackmann; A Wells; J Ludgate; M Gelder
Journal:  J Consult Clin Psychol       Date:  1999-08

Review 3.  The cholecystokinin hypothesis of anxiety and panic disorder.

Authors:  J Bradwejn; D Koszycki
Journal:  Ann N Y Acad Sci       Date:  1994-03-23       Impact factor: 5.691

4.  Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias.

Authors:  D V Sheehan; J Davidson; T Manschreck; J Van Wyck Fleet
Journal:  J Clin Psychopharmacol       Date:  1983-02       Impact factor: 3.153

5.  A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.

Authors:  Y Lecrubier; A Bakker; G Dunbar; R Judge
Journal:  Acta Psychiatr Scand       Date:  1997-02       Impact factor: 6.392

6.  Effects of psychological intervention on panic attack patients in the emergency department.

Authors:  J M Dyckman; R L Rosenbaum; R J Hartmeyer; L J Walter
Journal:  Psychosomatics       Date:  1999 Sep-Oct       Impact factor: 2.386

7.  An open-label trial of nefazodone in high comorbidity panic disorder.

Authors:  N A DeMartinis; E Schweizer; K Rickels
Journal:  J Clin Psychiatry       Date:  1996-06       Impact factor: 4.384

8.  Panic disorder in a managed care environment.

Authors:  M H Rapaport; J J Cantor
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

9.  Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder.

Authors:  R B Lydiard; W A Morton; N P Emmanuel; J J Zealberg; M T Laraia; G W Stuart; P M O'Neil; J C Ballenger
Journal:  Psychopharmacol Bull       Date:  1993

Review 10.  Pharmacotherapy of panic disorder: differential efficacy from a clinical viewpoint.

Authors:  J A den Boer
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.